These results are consistent with results from FGF21 in 3T3L1 cells [1], [14] and opens up the possibility of FGF21 as a glucose lowering therapeutic in new onset type 1 diabetes. This evidence concerns the gene FGF21 and type 1 diabetes mellitus.